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Many chemicals in the aquatic environment are able to adversely affect in vitro brain and 
ovarian aromatase expression/activity. However, it remains to be determined if these 
substances elicit in vivo effect in fish. With the view to further understanding possible effects 
of endocrine disrupting chemicals (EDCs) on aromatase function, we first developed methods 
to measure brain and ovarian aromatase expression/activity in a model species, the zebrafish, 
and assessed the effect of estradiol (E2) and androstatrienedione (ATD), a steroidal aromatase 
inhibitor. We showed that CYP19b gene was predominantly expressed in the brain whereas in 
the ovary CYP19a mRNA level was predominant. Moreover, aromatase activities (AA) were 
higher in brain than in ovary. In adult zebrafish, E2 treatment had no effect on aromatase 
expression/activity in brain, whereas at larval stage, E2 strongly triggered CYP19b 
expression. In the ovaries, E2 led to a complete inhibition of both CYP19a expression and 
AA. Exposure to ATD led to a total inhibition of both brain and ovarian AA but had no effect 
on CYP19 transcripts abundance. Together, these results provide relevant knowledge 
concerning the characterization of aromatase in the zebrafish, and reinforce the idea that brain 
and ovarian aromatase are promising markers of EDCs in fish and deserve further in vivo 
studies.  
 




To date, most attention on endocrine disrupting chemicals (EDCs) has been focused on 
compounds that interact with the estrogen receptor (ER). However, the endocrine system may 
also be disrupted by environmental substances through pathways and mechanisms others than 
those that are ER-mediated. Function of the hypothalamic-pituitary-gonadal (HPG) axis can 
be affected by xenobiotics that affect metabolism of sex steroid hormones. In this regard the 
biosynthesis of steroid hormones provides enzymatic targets for EDCs, particularly the steps 
catalysed by cytochrome P450-dependent enzymes (Sanderson and Van den Berg, 2003). 
Among these enzymes, cytochrome P450 aromatase (CYP19) is a crucial steroidogenic 
enzyme catalysing the final, rate-limiting step in the conversion of androgens into estrogens 
(Simpson et al., 1994). Recent studies reported alteration of steroidogenesis associated with 
adverse reproductive effects in wild fish collected from contaminated sites (Noaksson et al., 
2001; Orlando et al., 2002; Lavado et al., 2004). However the nature (and the levels) of 
substances involved in these biological responses remains to be determined. In the laboratory, 
different substances from diverse chemical family have been shown to disrupt vertebrate 
aromatase (Monteiro et al., 2000; Sanderson et al., 2002). In fish, however, most of the data 
were obtained from in vitro studies (Monod et al., 1993)and little is known about their in vivo 
effects.  
The purpose of this study was to assess the effect of the natural steroidal estrogen, estradiol 
(E2), product of the aromatisation reaction, and androstratienedione (ATD), a steroidal 
aromatase inhibitor, on aromatase expression and activities in the zebrafish (Danio rerio). The 
zebrafish is a prominent vertebrate model in a variety of biological discipline (Hill et al., 
2005) and is extensively used for assessing the effects of estrogenic compounds at various 
biological levels of organization (Brion et al., 2002, 2004; Fenske and Segner, 2004; Nash et 
al., 2004). In the zebrafish, two distinct aromatase genes have been isolated (CYP19a and 
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CYP19b) and their 5'-flanking region characterised (Kazeto et al., 2001). While their tissue 
and ontogenic expression profiles are relatively well described (Trant et al., 2001), data on 
brain and ovarian AA in control and exposed-zebrafish are missing. With the view to further 
understanding possible effects of EDCs on aromatase function, detailed information on gene 
expression and enzyme activities in both the gonads and brain are needed and this was the 
first aim of this study. 
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MATERIAL AND METHODS 
 
Fish exposure to E2 and ATD 
 
Wild type zebrafish (Danio rerio) were obtained from our breeding unit. Female zebrafish 
were exposed for 7 days to 17- -estradiol (E2, 10 nM), 1,4,6-androstatrien-3,17-dione (ATD, 
1 µM) or solvent (DMSO). Exposures were realised under semi-static conditions with a total 
renewal of the water every day. Each substance was tested in duplicate separated tanks. One 
replicate was used to measure aromatase activity (N = 10 fish), and the other one to measure 
CYP19 mRNA levels (N = 7 fish). 
Zebrafish larvae of 17 days post fertilisation (dpf) were exposed to either E2 (10 nM) alone or 
in combination with ICI 182-780 (Tocris, USA) or to solvent alone (DMSO) for 72 hours. 
Each experimental group was constituted of 20 zebrafish larvae exposed in 100 ml of water. 
One half of the water was renewed every day.  
 
Fish dissection and tissue sampling 
 
Adult fish were euthanized by an overdose of MS-222, measured and weighted. Brain and 
gonads were removed, weighted and the gonado somatic index (GSI) was calculated.  
Tissues (or larvae) used for subsequent determination of mRNA levels were immediately 
stored at 4°C in a solution of RNAlaterTM (Sigma-Aldrich, France). Samples were kept at 4°C 
overnight and conserved at 20°C until measurement. For AA measurement, tissues were 
rinsed in ice cold KCl (0.15 M) and homogenised in a 50 mM potassium phosphate buffer, pH 
7.4, containing 1 mM PMSF, 1 mM EDTA and 20% glycerol (v/v) in a ratio of 1:2 (w/v). S9 
fractions were isolated by centrifugation of the homogenates (10 000 g, 15 min, 4°C). For the 
brains, S9 were aliquoted and stored at –80°C until used while for the ovaries, supernatants 
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were subsequently ultra-centrifuged at 100,000 g (90 min, 4°C). AA were measured in 
ovarian microsomes instead of S9 fractions to avoid variation of protein content during the 
reproductive cycle which may lead to incorrect measurement of AA in this tissue. The 
microsomal pellets were resuspended in the same buffer as used for the homogenisation. The 
total amount of proteins was determined by the method of Bradford with BSA (Bovine Serum 
Albumin, Sigma-Aldrich, France) as standard (Bradford, 1976). 
 
Determination of CYP19a and CYP19b mRNA levels  
 
CYP19 mRNA levels were measured by a branched DNA assay (QuantiGene, Genospectra, 
USA). It directly measures RNA and does not require reverse transcription and cDNA 
amplification. The bDNA assays were performed according to the manufacturer instructions. 
Tissues (or 10 pooled whole-body zebrafish larvae) were lysed and incubated in a 96-well 
plate coated with synthetic oligonucleotide in the presence of a specific probe set designed 
according to the CYP19a and CYP19b mRNA sequences (gene bank accession number 
AF183906 and AF183908 respectively). Capture probe allowed capture of the target mRNA 
to the synthetic oligonucleotide. Blocking Probe linearised the target mRNA and a label probe 
hybridised to the target mRNA and to a branched DNA (bDNA) coupled with Alkaline-
Phosphatase-bound Probes. Addition of a chemiluminescence substrate (Dioxetan) yields a 
luminescence signal that is proportional to the amount of mRNA present in the sample. 
Quantification of luminescence was made on a microplate luminometer (Victor2, Perkin 
Elmer, France). CYP19 expression values were normalised to a housekeeping gene, zf -actin 
(gene bank accession number NM 131031). Measurement of target and housekeeping genes 





Brain and ovarian AA were measured in individual fish by the tritiated water assay modified 
from Thompson and Siiteri (1974). The following additions were made in a final volume of 
500 µL : 200 µg of microsomal proteins (ovary) or S9 fraction proteins (brain), 20 µM of 
NADPH, 1 mM of NADP, 10 mM of G6P, 2 U/ml of G6PDH, 50 mM potassium phosphate 
buffer, pH 7.4. The mixture was preincubated at 27 °C for 10 min, and the reaction started 
with the addition of 150 nM of [1β-3H (N)]androst-4-ene-3,17-dione (Perkin Elmer, France). 
The reaction was stopped after 1 h of incubation by adding 1 ml of chloroform. The aqueous 
layer was extracted twice with chloroform and once with charcoal (5%, w/v). 150 µL of the 
aqueous phase was mixed with 750 µL of OptiPhase ‘Hi safe’ 3 (Perkin Elmer, France) before 
scintillation counting (Microbeta, Perkin Elmer, France). AA measurements were realised in 
duplicates. Results were expressed in fmol/mg/min. 
 
Data analysis and statistics 
 
Differences between groups were analysed for statistical significance with the Student’s t-test. 
Results are expressed as means ± standard deviation, and differences between groups were 





Baseline aromatase expression and activity in adult female zebrafish  
 
The transcript abundance for CYP19a and CYP19b genes is shown in the Fig. 1A. In the 
brain, levels of CYP19b mRNA expression was about 45-fold higher than CYP19a 
expression, while, in the ovaries, levels of CYP19a mRNA expression was about 3-fold 
higher than CYP19b expression. Moreover, the level of expression of CYP19b was higher in 
the brain than the expression of CYP19a in the ovary. At enzymatic level, AA measured in 
female zebrafish by the tritiated water assay were higher in brain than in ovaries (Fig. 1B). 
There was about a 4-fold difference between brain and ovarian AA (34.0  25.3 and 8.1  8.2 
fmol/mg/min respectively).  
 
Effect of exposure to E2 and ATD 
 
In adult female zebrafish, E2 exposure had no effect on CYP19b expression in the brain but 
significantly inhibited CYP19a expression in the ovary (Fig. 2A). At enzymatic level, brain 
AA were not affected, but ovarian AA were totally inhibited (Fig. 2B).  
In zebrafish larvae exposed between 17 and 20 dpf to E2 , there was no significant effect on 
CYP19a expression. However, a 16-fold increase in CYP19b expression was measured (Fig. 
3). In addition, co-treatment with the pure antagonist of the ER receptor ICI 182-780 led to a 
significant inhibition of the E2-induced CYP19b mRNA levels.  
In ATD-exposed fish, there were no significant effects neither on the transcript abundance of 
CYP19b gene in the brain nor on CYP19a expression in the ovary (Fig. 4A). However, ATD 




CYP19 genes expression and AA in adult female zebrafish 
 
In contrast to mammals, many teleosts fish possess two forms of the aromatase gene in their 
genome, as it was demonstrated for zebrafish (Kishida and Callard, 2001). CYP19a and 
CYP19b transcripts, as measured by the bDNA assays, were both detected in ovarian and 
brain tissues of adult female zebrafish which is in agreement with previously reported CYP19 
genes expression measured by RT-PCR (Trant et al., 2001; Fenske and Segner, 2004). In the 
ovary, CYP19a mRNA level was higher compared to CYP19b, whereas CYP19b expression 
was predominant in the brain. Cerebral CYP19b was shown to be expressed at particularly 
high levels in adult female (about 600 fold CYP19a expression in the ovary) which is well in 
accordance with the difference observed by Trant et al. (2001). At the cellular level, ovarian 
CYP19a expression was localised in granulosa cells surrounding follicules (Goto-Kazeto et 
al., 2004); in the brain, P450aromataseB (AroB) was found to be express exclusively in radial 
glial cells at high levels in males and females (Menuet et al., 2005). Teleosts fish are well 
known for their exceptionally high cerebral levels of aromatase ( Pasmanik and Callard, 1988; 
Callard et al., 2001). However, the functional outcomes of elevated aromatase expression in 
the brain of teleosts fish are still unresolved. Since teleosts fish shows a continuous 
neurogenesis throughout life, one hypothesis is that the high levels of neuroestrogens 
synthesis in adult may be related to the remarkable neuroplasticity and regenerative potential 
of the adult fish central nervous system (Callard et al., 2001; Forlano et al., 2001).  
Further characterisation was achieved by measuring brain and ovarian AA in female 
zebrafish. In agreement with the CYP19 transcripts abundance, we showed that brain AA 
were significantly higher than ovarian AA which is in accordance with the general pattern of 
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AA described in other teleosts fish (Pasmanik and Callard, 1988; Gonzalez and Piferrer, 
2002). These differences can be accounted for differences in the levels of mRNA expression 
in the two tissues (Trant et al., 2001; our study) and/or be due to the higher catalytic activity 
(Vmax) of the brain aromatase compared to the ovarian aromatase (data not shown).  
 
Effect of exposure of zebrafish E2 and ATD on CYP19 expression and AA  
 
At adult stage, E2 had no significant effect on CYP19b expression and AA in the brain of 
female zebrafish. In contrast, short-term exposure of zebrafish larvae to E2 strongly up-
regulated CYP19b expression. This result confirms previous data obtained by RT-PCR on 
RNA from total zebrafish embryos and larvae exposed to E2 (Kishida and Callard, 2001). In 
toto hybridisation and immunohistochemistry experiments further revealed that E2 causes 
strong expression of AroB messengers and proteins in radial glial cells of zebrafish embryos 
and larvae (Menuet et al., 2005). Additionally, the E2 dependant induction of the CYP19b 
gene was blocked by co-treatment with an excess of the pure ER antagonist ICI 182-780 
indicating that functional ERs were involved. In teleosts fish brain, CYP19b gene is known to 
be under the control of a positive autoregulatory feedback loop driven by E2, the product of 
aromatization (Callard et al., 2001). On a molecular basis, it was recently demonstrated that 
the E2-dependent regulation involves a direct transcriptional action of ERs requiring the 
synergistic effect of ERE and ½ ERE in the promoter region of the CYP19b gene (Menuet et 
al., 2005). The absence of effect of E2 on aromatase in adult zebrafish brain is not surprising 
since the endogenous estrogenic stimulation on aromatase expression/activities is already high 
due to the positive autoregulatory feedback loop driven by E2 (Callard et al., 2001). Our 
results clearly demonstrated that the CYP19b expression is very sensitive to (xeno)-estrogen 
in zebrafish larvae in comparison with adult fish and reinforce the idea that AroB is a 
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promising marker of estrogenic compounds in zebrafish early life stages (Menuet et al., 
2005). In contrast to the dramatic alteration of the CYP19b gene expression, E2 had no effect 
on CYP19a expression in zebrafish larvae. In zebrafish fry exposed to high concentration of 
EE2, conflicting results were obtained since RT-PCR analysis revealed no effect or down-
regulation of the CYP19a gene (Trant et al., 2001; Kazeto et al., 2004). At adult stage, both 
CYP19a expression and AA were totally inhibited in the ovary of E2-exposed fish and our 
results suggest that the inhibitory effect of E2 on AA in ovary of mature female is mediated 
through a transcriptional inhibition of the CYP19a gene. However, the exact mechanism of 
action of E2 on CYP19a expression remains to be determined. It may be attributed to a 
negative feedback action of E2 on gonadotropins release, which are known to stimulate 
aromatase gene expression and activities in ovarian follicles (Gen et al., 2001; Kagawa et al., 
2003). However, a direct effect of E2 on the ovary cannot be excluded. Indeed, it has been 
demonstrated that the inhibitory effect of E2 on steroidogenic enzymes mRNA levels in 
undifferentiated testis of rainbow trout did not imply follicle stimulating hormone (Baron et 
al., 2005). The absence of ERE in the promoter region of CYP19a gene do not support an ER-
mediated effect. It is interesting to note that similar concentration of E2 leads to an alteration 
of oogenesis in females, the ovaries of exposed fish being composed mainly of immature 
oocytes (Brion et al., 2000). It can be suggested that the effects seen at histological level are 
mediated, at least in part, by inhibition of ovarian aromatase.  
Exposure of female zebrafish to the steroidal aromatase inhibitor ATD resulted in 
dramatic inhibition of AA in both brain and ovary. ATD is known to inhibit vertebrate 
aromatase by binding irreversibly to the active site of the enzyme (Yue and Brodie, 1997). We 
previously showed that ATD exhibited a high efficiency at inhibiting in vitro brain and 
ovarian microsomal AA in rainbow trout (Hinfray et al., 2004). The in vivo effects of ATD on 
AA are thus consistent with the in vitro inhibitory effect of this molecule. In contrast to the 
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effect seen at the enzymatic level, exposure to ATD had no effect neither on the 
transcriptional activity of the CYP19b gene nor the CYP19a gene. As previously stated, 
CYP19b transcription in fish brain is up-regulated by E2 through a positive feedback loop 
(Callard et al., 2001). Thus, it could be expected that the local deprivation of E2 due to 
aromatase inhibition in the brain could lead to a decreasing transcript abundance of the 
CYP19b gene. The absence of effect might be due to the short-term exposure duration of fish 
to ATD and it is likely that a prolonged exposure time would result in a significant effect, as 




This study provides relevant data on aromatase expression at the gene and enzymatic levels in 
brain and in ovary of adult female fish. We showed that CYP19b expression was predominant 
in brain whereas CYP19a expression was predominant in ovary and that AA were higher in 
brain than in ovary. Our results indicate that E2 and ATD exposures deeply affect aromatase 
expression and/or activities in the zebrafish. The observed effects were dependent on the sub-
cellular level at which aromatase function was assessed (gene expression, AA), the target 
tissue (brain, ovary) and the life stage of development (larvae, adult). From these results it 
appears that measurements of both CYP19 gene expression and AA in the zebrafish are 
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Fig. 1 : Relative transcript abundance of CYP19a and CYP19b gene (normalised to beta-actin 
transcript abundance in the same samples) (A) and aromatase activity (B) measured in brain 
and ovary of adult female zebrafish. Results are expressed as means and SD. Different letters 
indicate statistically different values (Student’s t-test, p < 0.05) 
 
Fig. 2 : Effect of E2 on CYP19a and CYP19b in ovary and brain respectively (A) and on 
aromatase activity (B). Results are expressed as means and SD. SC = solvent control.  
Different letters indicate statistically different values (Student’s t-test, p < 0.05). 
 
Fig. 3 : Effect of E2 alone or in combination with ICI 182-780 on CYP19a and CYP19b 
transcript abundance in zebrafish larvae after a 72 hours in vivo exposure between 17 and 20 
dpf. SC = solvent control. N = 2 replicate for each group tested (one replicate correspond to 
10 larvae). Different letters indicate statistically different values (Student’s t-test, p < 0.05). 
 
Fig. 4 : Effect of ATD on CYP19a and CYP19b transcript abundance in ovary and brain 
respectively (A) and on aromatase activity (B). Results are expressed as means and SD. SC = 
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